Document:

Document

Exhibit 10.1

July 19, 2021

VIA EMAIL/DOCUSIGN

Dear Ms. Cavanaugh,

As discussed, effective as of the filing date of Apollo Endosurgery, Inc.’s (the “Company”) Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Effective Date”), which is expected to be on or about August 3, 2021, you will cease serving as Chief Financial Officer of Apollo Endosurgery, Inc. (the “Company”) and will remain employed in a transitional role at the Company.  In this new role, you will report to the Chief Financial Officer of the Company.

Between now and the Effective Date, you and the Company will negotiate a new employment agreement to reflect your new role.  The Company agrees that, at a minimum, any new employment agreement will provide for the same level of severance benefits and related severance terms and conditions at least as favorable to you as those provided under your Employment Agreement dated March 2, 2015, as amended on May 23, 2018 (the “Employment Agreement”).

If you and the Company are not able to reach agreement on a new employment agreement by the Effective Date, then you will remain employed under the terms of your Employment Agreement, as amended by the terms herein, through January 31, 2022, at which time your employment will automatically end and you will be entitled to severance benefits under Section 8(d)(ii) of your Employment Agreement.

You will remain eligible for a 2021 bonus, subject to the terms and conditions set forth in the Employment Agreement and the Company’s incentive bonus plan (including any requisite approvals by the Company’s board of directors or any committee thereof), provided you remain employed through the January 31, 2021. 

The Company acknowledges that this change in your role constitutes Good Reason for your resignation under the terms of your Employment Agreement and agrees that between now and January 31, 2022, you may elect to resign for Good Reason upon providing notice of same to the Company, with at least fifteen (15) days’ notice of your final day of employment.  In the event you provide such notice, the Company will provide you with the severance benefits set forth in Section 8(d)(ii) of your Employment Agreement, subject to the terms and conditions therein.  You understand and agree that your right to resign for Good Reason based on this transition will expire as of January 31, 2022.

Except as set forth herein, all of the terms and conditions of your employment as set forth in the Employment Agreement shall remain in effect and unchanged.

Please sign below to indicate your acceptance of these amended terms and conditions of employment.

Sincerely,

/s/ Charles McKhann            
Charles McKhann
Chief Executive Officer and President

Understood, Accepted and Agreed To:

/s/ Stefanie Cavanaugh                    7/19/2021            
Stefanie Cavanaugh                    DateDocument

Exhibit 10.2

EMPLOYMENT AGREEMENT
for
Jeff Black

This EMPLOYMENT AGREEMENT (the “Agreement”) is hereby entered into by and between Apollo Endosurgery, Inc. (the “Company”) and Jeff Black (“Executive”)(Executive, together with the Company, the “Parties”). 
WHEREAS, the Company desires to employ Executive pursuant to the terms, provisions and conditions set forth in this Agreement; and
WHEREAS, Executive desires to be employed on the terms set forth in this Agreement; 
NOW, THEREFORE, in consideration of the promises and the mutual covenants herein contained, the Parties hereby agree as follows:
1.At-Will Employment.  Executive shall be employed by the Company on an at-will basis, meaning either the Company or Executive may terminate Executive’s employment at any time, with or without Cause (as defined below) or advanced notice.  Any contrary representations that may have been made to Executive shall be superseded by this Agreement.  This Agreement shall constitute the full and complete agreement between Executive and the Company on the “at will” nature of Executive’s employment, which may only be changed in an express written agreement signed by Executive and a duly authorized officer of the Company (other than Executive).  Executive’s rights to any compensation following a termination of employment shall be only as set forth in Section 8 below.  
2.Position and Duties.  Executive shall serve as the Company’s Chief Financial Officer.  Executive shall perform duties customary to such position, as reasonably assigned to him from time to time by the Chief Executive Officer, to whom Executive shall report.  Executive shall devote Executive’s full business time and attention to the performance of Executive’s duties hereunder and shall comply with all applicable laws, rules and regulations to which the Company is subject and all Company policies to which Executive is subject.  Executive shall not engage in any other business, profession or occupation for compensation or otherwise that would conflict or interfere with the rendition of such services; provided, that nothing herein shall preclude Executive from (i) with the prior written consent of the Board, serving on the board of directors of other for-profit companies that do not compete with the Company, (ii) serving on civic or charitable boards or committees, and (iii) managing personal investments, so long as all such activities described in (i) through (iii) herein do not materially interfere with the performance of Executive’s duties and responsibilities under this Agreement. Executive shall perform Executive’s duties at his home office in Carlsbad, California and at the Apollo Endosurgery corporate offices in Austin, Texas as required.  Executive shall commence employment, and this Agreement shall be effective, on August 1, 2021. (the “Effective Date”).

3.Compensation, Policies and Benefits.
(a)Base Salary.  The Company shall pay Executive an initial base salary for services rendered under this Agreement at an annualized rate of $375,000.00 (the “Base Salary”), less standard payroll deductions and withholdings.  Executive shall be paid in accordance with Company practice and policy. Executive’s Base Salary shall be reviewed and adjusted from time to time by the Board of Directors (the “Board”) or a duly authorized committee.
(b)Annual Bonus.  Subject to the achievement, as determined by the Board or a duly authorized committee thereof in good faith, of performance milestones mutually agreed upon by Executive and the Board or a duly authorized committee thereof, and based on such other criteria as determined by the Board or a duly authorized committee thereof in its sole discretion, Executive shall be eligible to earn an annual cash bonus (“Annual Bonus”) in a target amount of sixty percent (60%) of Executive’s then-current Base Salary (“Bonus Target”).  For calendar year 2021, Executive’s bonus eligibility shall be pro-rated based on the percentage of the year Executive is employed.  If Executive leaves the employ of the Company prior to payment of any Annual Bonus, except as set forth in Sections 8(a), 8(b) and 8(d), Executive will not have earned, and will not be eligible for, an Annual Bonus, pro-rated or otherwise. Except as set forth in Section 8(a), 8(b), and 8(d), Executive must be employed on the day the Annual Bonus (if any) is paid in order to earn the Annual Bonus.  Except as set forth in Section 8(d), the Annual Bonus earned for any given year will be paid to Executive on the date on which annual bonuses are paid to all other senior executives of the Company, but in no event later than March 15 of the year following the year in which Executive’s right to the Annual Bonus is no longer subject to a substantial risk of forfeiture, so as to comply with Treasury Regulation Section 1.409A-1(b)(4). 
(c)Equity Grants.  
(i)Time-Based Vesting Option.  Executive will be issued an option (the “Option”) to purchase 150,000 shares of the Company’s common stock pursuant to a written Stock Option Agreement between Executive and the Company.  The Company will use its reasonable best efforts to issue the Option as soon as possible following the Effective Date.  Except as set forth in Section 8(d), the Option shall vest and become exercisable according to the following schedule: 25% of the shares will vest as of one year from the Effective Date, and the remaining 75% of the shares will vest in equal monthly installments at the end of each calendar month thereafter over the following three (3) years, subject to Executive’s Continuous Service (as defined in Section 12(o) of the Company’s 2017 Equity Incentive Plan) with the Company on such dates.  The Option will be a nonqualified stock option (to the extent permitted by law) and will have an exercise price per share based upon the fair market value of the Company’s common stock on the date of grant.  Executive may be eligible for additional annual equity grants at the discretion of the Board. 
(ii)Time-Based Vesting RSUs.  Executive will be issued a second grant consisting of a restricted stock unit award for 80,000 shares pursuant and subject to a written Equity Agreement between Executive and the Company (the “RSUs”).  The Company 
2

will use its reasonable best efforts to issue the RSUs as soon as possible following the Effective Date.  25% of the RSUs will vest as of one year from the Effective Date, and the remaining 75% of the shares will vest in equal quarterly installments thereafter over the following three (3) years, subject to Executive’s Continuous Service (as defined in Section 12(o) of the Company’s 2017 Equity Incentive Plan) with the Company on such dates.  
(iii)Performance-Based Vesting Restricted Stock Units.  Executive will be issued a second grant consisting of a restricted stock unit award for 120,000 shares of the Company’s common stock pursuant and subject to a written Equity Agreement between Executive and the Company (the “Performance-Based Vesting RSU”, and together with the Option and the RSUs, the “Awards”).  The Company will use its reasonable best efforts to issue the Performance-Based Vesting RSU as soon as possible following the Effective Date. The Performance-Based Vesting RSU shall vest according to the following schedule: (a) one-third (1/3) of the shares subject to the Performance-Based Vesting RSU will vest upon achievement by the Company of $70 million in annual revenue; (b) one-third (1/3) of the shares subject to the Performance-Based Vesting RSU will vest upon achievement by the Company of $90 million in annual revenue; and (c) the remaining shares subject to the Performance-Based Vesting RSU will vest upon achievement by the Company of $110 million in annual revenue.  In the event that any shares subject to the Performance-Based Vesting RSU have not vested on the earlier of Executive’s last day as an Employee, Consultant, or Non-Employee Director (in each case, as defined in the 2017 Equity Incentive Plan) and the end of the sixteenth (16th) full fiscal quarter following the Effective Date, the unvested shares of the Performance-Based Vesting RSU shall expire in its entirety on that date. For purposes of determining achievement of vesting conditions of the Performance-Based RSU, annual revenue shall be calculated on the basis of the trailing completed four (4) fiscal quarters, which shall only include full quarters during which Executive is employed under this Agreement.  In the event of a Change in Control (as defined in the 2017 Equity Incentive Plan), the Performance-Based Vesting RSU shall accelerate as follows: (i) if the Change in Control occurs in a transaction in which the deemed value per share of the Company’s common stock is at least one and one-half (1 1⁄2) times the last reported sale price of the Company’s common stock on The Nasdaq Global Market on the grant date of the Performance-Based Vesting RSU (the “Closing Price”), but less than two (2) times the Closing Price, fifty percent (50%) of the unvested shares subject to the Performance-Based Vesting RSU shall vest as of immediately prior to effectiveness of such Change in Control, and (ii) if the Change in Control occurs in a transaction in which the deemed value per share of the Company’s common stock is at least two (2) times the Closing Price, one-hundred percent (100%) of the unvested shares subject to the Performance-Based Vesting RSU shall vest as of immediately prior to effectiveness of such Change in Control.  In addition, the Awards shall be subject to the vesting acceleration provision set forth in Section 8(d)(iii) below.
4.Company Policies and Benefits.  The employment relationship between the Parties shall also be subject to the Company’s personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole discretion.  Executive shall be eligible to participate in the employee benefit plans of the Company on a basis no less favorable than such benefits are provided by the Company from time to time to the Company’s other senior executives.  All matters of eligibility for coverage or benefits under any 
3

benefit plan shall be determined in accordance with the provisions of such plan or program.  The Company reserves the right to change, alter, or terminate any benefit plan in its sole discretion. Notwithstanding the foregoing, in the event that the terms of this Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement shall control. 
5.Vacation, Sick Leave and Holidays.  Executive shall be eligible to accrue four (4) weeks of paid vacation and sick days during each year in accordance with the Company’s vacation and sick leave policies and the restrictions on carry-over, payout and use contained therein.  Executive shall also be entitled to all paid holidays given by the Company to its senior executives, administered in accordance with the Company’s holiday policies. 
6.Expense Reimbursement.  Executive shall be eligible to receive prompt reimbursement for all travel and business expenses reasonably incurred and accounted for by Executive (in accordance with the policies and procedures established from time to time by the Company) in performing services hereunder. For the avoidance of doubt, to the extent that any reimbursements (including any taxable benefits reimbursements) are subject to the provisions of Section 409A of the Code: (a) to be eligible to obtain reimbursement for such expenses Executive must submit expense reports within 30 days after the expense is incurred, (b) any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was incurred, (c) the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year, and (d) the right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.
7.Indemnification; D&O Coverage.  The Company, and its successors and/or assigns, will indemnify and defend Executive to the fullest extent permitted by the By-Laws and Certificate of Incorporation of the Company with respect to any claims that may be brought against Executive arising out of any action taken or not taken in Executive’s capacity as an officer or director of any member of the Company pursuant to the terms and conditions of the Indemnification Agreement between the Parties of even date herewith (the “Indemnification Agreement”).  In addition, Executive shall be covered as an insured in respect of Executive’s activities as an officer of the Company by the Company’s Directors and Officers liability policy or other comparable policies obtained by the Company’s successors, to the fullest extent permitted by such policies.  The Company’s indemnification obligations hereunder shall remain in effect following Executive’s termination of employment with the Company.
8.Termination of Employment.  The Parties acknowledge that as set forth in Section 1 of this Agreement, Executive’s employment relationship with the Company is at-will.  Either Executive or the Company may terminate the employment relationship at any time, with or without Cause.  The provisions in this Section 8 govern the amount of compensation, if any, to be provided to Executive upon termination of employment and do not alter this at-will status. 
(a)Death.  Executive’s employment shall terminate upon Executive’s death.  Upon any such termination, Executive’s estate shall be entitled to receive his Base Salary, accrued but unused paid vacation through the date of termination, together with any compensation and benefits payable to Executive based on his participation in any compensation 
4

or benefit plan, program or arrangement through the date of termination (together, the “Accrued Amounts”).  The Accrued Amounts shall be timely paid following the date of termination in accordance with applicable laws, not to exceed thirty (30) days.  Any vested options will be exercisable by Executive’s estate until the earlier of eighteen (18) months after his death or the expiration date of the options.  All other benefits, if any, due to Executive’s estate following Executive’s termination due to death shall be determined in accordance with the plans, policies and practices of the Company; provided, that Executive’s estate shall not be entitled to any payments or benefits under any severance plan, severance policy or similar program of the Company.  Executive’s estate shall not accrue any additional compensation (including any Base Salary or Annual Bonus) or other benefits under this Agreement following the effective date of the termination of employment due to Executive’s death. 
(b)Disability.  The Company may terminate Executive’s employment for Disability.  “Disability” shall mean Executive’s inability, due to physical or mental incapacity, to perform  the essential functions of his position for a period of ninety (90) consecutive days or one hundred twenty (120) days during any consecutive six (6) month period, or based on the written certification by two licensed physicians of the likely continuation of such condition for such period.  This definition shall be interpreted and applied consistent with the Americans with Disabilities Act, the Family and Medical Leave Act, and other applicable law.  In conjunction with determining Disability for purposes of this Agreement, Executive hereby (i) consents to not more than two (2) reasonable medical examinations which are relevant to a determination of whether Executive is mentally and/or physically disabled, and (ii) agrees to furnish such medical information as may be reasonably requested for such determination.  Upon any such termination, Executive shall be entitled to receive payment of the Accrued Amounts. All other benefits, if any, due to Executive following Executive’s termination by the Company for Disability shall be determined in accordance with the plans, policies and practices of the Company; provided, that Executive shall not be entitled to any payments or benefits under any severance plan, severance policy or similar program of the Company.  Executive shall not accrue any additional compensation (including any Base Salary or Annual Bonus) or other benefits under this Agreement following the effective date of the such termination of employment.
(c)Termination for Cause; Termination by Executive without Good Reason.  At any time, (i) the Company may terminate Executive’s employment for Cause (as defined below) by Notice of Termination (as defined in Section 8(e)) or (ii) Executive may elect to terminate Executive’s employment other than for Good Reason (as defined below); provided, that Executive shall be required to give, at least thirty (30) days in advance, a Notice of Termination, and the Company may elect to accelerate the timing of Executive’s termination date upon receipt of such notice.  “Cause” for Executive’s termination will exist for a period of ninety (90) days following the Company’s discovery of the happening of one or more of the following events: (i) Executive’s gross negligence or willful misconduct in performance of his duties hereunder where such gross negligence or willful misconduct has resulted in or is likely to result in substantial and material damage to the Company or any of its subsidiaries; (ii) Executive’s repeated absence from the Company in violation of Company policy or the written instructions of the Board, provided, Executive shall have a period of ten (10) days to cure such absence after receipt of written notice thereof; (iii) Executive’s material and willful violation of 
5

any federal or state law that has resulted in or is likely to result in substantial and material damage to the Company or any of its subsidiaries; (iv)  the commission of any act of fraud by Executive with respect to the Company; (v) Executive’s conviction of a felony or a crime involving moral turpitude causing material harm to the standing and reputation of the Company; or (vi) Executive’s incurable material breach of the Company’s Invention, Confidential Information and Non-Competition Agreement (the “Non-Competition Agreement”), including without limitation, Executive’s theft or other misappropriation of the Company’s proprietary information.   Upon the termination of Executive’s employment pursuant to this Section 8(c), Executive shall be entitled to receive payment of the Accrued Amounts.  All other benefits, if any, due to Executive following Executive’s termination of employment pursuant to this Section 8(c) shall be determined in accordance with the plans, policies and practices of the Company; provided, that Executive shall not be entitled to any payments or benefits under any severance plan, severance policy or similar program of the Company.  Executive shall not accrue any additional compensation (including any Base Salary or Annual Bonus) or other benefits under this Agreement following the effective date of such termination of employment.
(d)Termination for Good Reason or Without Cause.  
(i)Executive may terminate Executive’s employment for Good Reason (as defined below), provided the Company has not previously notified him in writing of its intent to terminate his employment for Cause, and the Company may terminate Executive’s employment without Cause (that is, other than by death, Disability or for Cause, in accordance with Section 8(a), 8(b) or 8(c), respectively, collectively, an “Involuntary Termination”).  “Good Reason” shall mean the occurrence, without Executive’s prior written consent, of any of the following events: (a) a material reduction in the nature or scope of Executive’s responsibilities, duties and/or authority; provided, that a change in job position (including a change in title) shall not be deemed a “material reduction” in and of itself unless Executive’s responsibilities, duties and/or authority are materially reduced; (b) a material reduction in Executive’s then-current Base Salary, which the Company and Executive agree is at least 10% of Executive’s then-current Base Salary; provided, that a reduction in Base Salary shall not be “Good Reason” to the extent the reduction is made as part of a broader compensation reduction program of the Company affecting a majority of similarly situated employees; (c) a material change in the location at which Executive must perform his services; provided, that in no event will the relocation of Executive to a facility or location of fifty (50) miles or less from Executive’s then current office location be deemed material for purposes of this Agreement; or (d) a material breach of this Agreement by the Company. No event described in clauses (a) through (d) above shall constitute Good Reason unless Executive delivers to the Company a Notice of Termination for Good Reason within ninety (90) days after the initial existence of the circumstances giving rise to Good Reason, within thirty (30) days following the receipt of such Notice of Termination for Good Reason the Company has failed to reasonably cure the circumstances giving rise to Good Reason, and Executive terminates his employment within thirty (30) days following the end of the 30 day cure period. 
(ii)Upon an Involuntary Termination pursuant to this Section 8(d), and provided such termination constitutes a “separation from service” (as defined under Treasury 
6

Regulation Section 1.409A-1(h), without regard to any alternative definitions thereunder, “Separation from Service”), the Company shall pay Executive the Accrued Amounts, and, subject to Executive’s (a) returning all Company property; (b) complying with his post-termination obligations under this Agreement and the Non-Competition Agreement; (c) execution, delivery and non-revocation of a general release of all claims against the Company within the sixty (60) day period following the effective date of Executive’s Involuntary Termination, (d) resigning from all positions held with the Company and any of its subsidiaries; and (e) complying with the Release including without limitation any non-disparagement and confidentiality provisions contained therein, Executive shall receive the following severance benefits (the “Severance Benefits”):  
(1)an amount equal to six (6) months of Executive’s then-current Base Salary, ignoring any decrease in Base Salary that forms the basis for Good Reason, paid in equal installments on the Company’s normal payroll schedule over the 6-month period immediately following the date of Involuntary Termination, except as set forth below (the “Salary Continuation”), plus an amount equal to the Annual Bonus, if any, earned in connection with completion of the fiscal year prior to Executive’s Involuntary Termination that would have been payable to Executive under Section 3(b) had Executive remained an employee of the Company through the Annual Bonus payment date for that fiscal year. 
(iii)If such Involuntary Termination (and provided that such termination constitutes a Separation from Service) occurs within three (3) months prior to (contingent upon the occurrence of the Change in Control), on or within twelve (12) months after a Change in Control, in lieu of the Severance Benefits described in Section 8(d)(ii)(1) above, Executive shall receive the following severance benefits (the “Change in Control Severance Benefits”):
(1)an amount equal to twelve (12) months of Executive’s then-current Base Salary, ignoring any decrease in Base Salary that forms the basis for Good Reason, paid in equal installments on the Company’s normal payroll schedule over the 12-month period immediately following the date of Involuntary Termination, except as set forth below (the “Change in Control Salary Continuation”), plus an amount equal to the Annual Bonus, if any, earned in connection with completion of the fiscal year prior to Executive’s Involuntary Termination that would have been payable to Executive under Section 3(b) had Executive remained an employee of the Company through the Annual Bonus payment date for that fiscal year;
(2)Should Executive elect to continue her medical, dental and/or vision insurance benefits pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) and any analogous provisions of applicable state law, the Company shall reimburse Executive for the COBRA premiums necessary to continue COBRA coverage for Executive and her eligible dependents (“COBRA Premiums”) from the date of Executive’s Involuntary Termination until the earliest to occur of (a) twelve (12) months following the Involuntary Termination, (b) the expiration of Executive’s eligibility for the continuation coverage under COBRA, and (c) the date when Executive becomes eligible for substantially 
7

equivalent health insurance coverage in connection with new employment or self-employment (such period from the date of the Change in Control Termination through the earliest of (a) through (c) is referred to herein as the “COBRA Benefits Payment Period”). Notwithstanding the foregoing, if the Company determines, in its sole discretion, that the Company cannot provide the COBRA Premium benefits without potentially incurring financial costs or penalties under applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof pay Executive a taxable cash amount, which payment shall be made regardless of whether Executive or Executive’s eligible family members elect health care continuation coverage (the “Health Care Benefit Payment”). The Health Care Benefit Payment shall be paid in monthly installments on the same schedule that the COBRA Premiums would otherwise have been paid to the insurer. The Health Care Benefit Payment shall be equal to the amount that the Company would have otherwise paid for COBRA insurance premiums (which amount shall be calculated based on the premium for the first month of coverage), and shall be paid until the expiration of the COBRA Benefits Payment Period. If Executive becomes eligible for coverage under another employer’s group health plan or otherwise ceases to be eligible for COBRA during the twelve (12) months following the Involuntary Termination, Executive must immediately notify the Company of such event; 
(3)(A) One hundred percent (100%) of the shares subject to the Option and the RSUs (and any other options and other equity awards subsequently granted to Executive outside the terms of this Agreement) shall become vested and exercisable (if applicable) as of the date of Executive’s Involuntary Termination under this clause (iii) and (B) the shares subject to the Performance-Based Vesting RSU shall become vested pursuant to Section 3(c)(iii); and 
(4)extension of the time period in which shares of the Performance-Based Vesting RSU may vest pursuant to the terms of Section 3(c)(iii) to the date that is the business day after the end of the day in which the Company reports its financial results for the second (2nd) completed fiscal quarter following the effective date of Executive’s Involuntary Termination under this clause (iii).
(iv)The Severance Benefits and Change in Control Severance Benefits will be subject to deductions for applicable tax withholdings. No Severance Benefits or Change in Control Severance Benefits will be paid prior to the day that is sixty (60) days following the date of Involuntary Termination. On the sixtieth (60th) day following the date of Involuntary Termination, the Company shall pay in a lump sum the aggregate amount of the Salary Continuation or the Change in Control Salary Continuation, as applicable, that the Company would have paid Executive through such date had the payments commenced on the Involuntary Termination through such sixtieth (60th) day, with the balance paid thereafter on the applicable schedules described above. 
(v)All other benefits, if any, due Executive following a termination pursuant to this Section 8(d) shall be determined in accordance with the plans, policies and practices of the Company; provided, that Executive shall not be entitled to any payments or benefits under any other severance plan, severance policy or similar program of the Company.  
8

Payments under this Agreement are intended to fulfill any statutory obligation to provide notice or pay in lieu of notice.  Executive shall not accrue any additional compensation (including any Base Salary or Annual Bonus) or other benefits under this Agreement following such the effective date of termination of employment.  
(e)Notice of Termination.  Any termination of Executive’s employment by the Company or by Executive shall be communicated by written notice of termination to the other Party in accordance with the Notice requirements set forth in Section 10(e) of this Agreement.  
(f)Taxes.  Notwithstanding any other provision of this Agreement to the contrary, if payments made or benefits provided pursuant to this Section 8 or otherwise from the Company or any person or entity are considered “parachute payments” under Section 280G of the Code, then such parachute payments shall be limited to the greatest amount that may be paid to Executive under Section 280G of the Code without causing any loss of deduction to the Company under such section, but only if, by reason of such reduction, the net after tax benefit to Executive shall exceed the net after tax benefit if such reduction were not made.  “Net after tax benefit” for purposes of this Agreement shall mean the sum of (i) the total amounts payable to Executive under Section 8, plus (ii) all other payments and benefits which Executive receives or then is entitled to receive from the Company or otherwise  that would constitute a “parachute payment” within the meaning of Section 280G of the Code, less (iii) the amount of federal and state income taxes payable with respect to the foregoing calculated at the maximum marginal income tax rate for each year in which the foregoing shall be paid to Executive (based upon the rate in effect for such year as set forth in the Code at the time of termination of Executive’s employment), less (iv) the amount of excise taxes imposed with respect to the payments and benefits described in (i) and (ii) above by Section 4999 of the Code.  The determination as to whether and to what extent payments are required to be reduced in accordance with this Section 8 shall be made at the Company’s expense by a nationally recognized certified public accounting firm as may be agreed to by the Company and Executive (the “Accounting Firm”) and the Company and Executive shall take all actions reasonably available to them in accordance with the law to minimize the amount of excise taxes imposed with respect to Section 4999 of the Code.  In the event of any mistaken underpayment or overpayment under this Agreement, as determined by the Accounting Firm, the amount of such underpayment or overpayment shall forthwith be paid to Executive or refunded to the Company, as the case may be, with interest at one hundred twenty (120%) of the applicable Federal rate provided for in Section 7872(f)(2) of the Code.  Any reduction in payments required by this Section 8(f) shall occur in the following order:  (1) any cash severance, (2) any other cash amount payable to Executive, (3) any benefit valued as a “parachute payment,” (4) the acceleration of vesting of any equity awards that are options, and (5) the acceleration of vesting of any other equity awards.  Within any such category of payments and benefits, a reduction shall occur first with respect to amounts that are not “deferred compensation” within the meaning of Section 409A and then with respect to amounts that are.  In the event that acceleration of compensation from equity awards is to be reduced, such acceleration of vesting shall be canceled, subject to the immediately preceding sentence, in the reverse order of the date of grant.
9

9.Invention, Confidential Information and Non-Competition Obligations; Non-Disparagement.  
(a)Invention, Confidential Information and Non-Competition Agreement. The Executive shall be required to execute and abide by the terms of the Company’s standard Confidential and Invention Assignment Agreement.  
(b)Non-Disparagement. Each Party agrees not to disparage the other Party, any member thereof, and any of their respective officers, attorneys, directors, managers, partners, employees, agents and affiliates, in any manner likely to be harmful to them or their business, business reputation or personal reputation; provided that a Party may respond accurately and fully to any question, inquiry or request for information when required by legal process.   
10.Miscellaneous.
(a)Executive’s Representations.  Executive hereby represents and warrants to the Company that (i) Executive has read this Agreement in its entirety, fully understands the terms of this Agreement, has had the opportunity to consult with counsel prior to executing this Agreement, and is signing the Agreement voluntarily and with full knowledge of its significance, (ii) the execution, delivery and performance of this Agreement by Executive does not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which he is bound, (iii) Executive is not a party to or bound by an employment agreement, non-compete agreement or confidentiality agreement with any other person or entity which would interfere in any material respect with the performance of his duties hereunder, and (iv) Executive shall not use any confidential information or trade secrets of any person or party other than the Company in connection with the performance of his duties hereunder.
(b)Waiver.  Expect with respect to adjustments provided for in Section 3(a), no provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in a writing signed by Executive and an officer of the Company (other than Executive) duly authorized by the Board to execute such amendment, waiver or discharge.  No waiver by either Party of any breach of the other Party of, or compliance with, any condition or provision of this Agreement shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
(c)Successors and Assigns. 
(i)This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by Executive otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by Executive’s legal representatives.
(ii)This Agreement shall inure to the benefit of and be binding upon the Company and its successors and, other than as set forth in Section 10(c)(iii), shall not be 
10

assignable by the Company without the prior written consent of Executive (which shall not be unreasonably withheld).
(iii)This Agreement shall be assignable by the Company to any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company; provided that, the Company shall require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law or otherwise.
(d)Notice.  For the purpose of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given if delivered personally, if delivered by overnight courier service, or if mailed by registered mail, return receipt requested, postage prepaid, addressed to the respective addresses, as the case may be, as set forth below, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt; provided, however, that (i) notices sent by personal delivery, email or overnight courier shall be deemed given when delivered, (ii) notices sent by facsimile transmission shall be deemed given upon the sender’s receipt of confirmation of complete transmission, and (iii) notices sent by registered mail shall be deemed given two days after the date of deposit in the mail.
If to Executive, to such address (including Company email address) as shall most currently appear on the records of the Company.

If to the Company, to its primary business location
Attention:  Board of Directors

(e)Governing Law; Consent to Jurisdiction.  THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF CALIFORNIA OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF CALIFORNIA TO BE APPLIED.  IN FURTHERANCE OF THE FOREGOING, THE INTERNAL LAW OF THE STATE OF CALIFORNIA WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS AGREEMENT, EVEN IF UNDER SUCH JURISDICTION’S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY.  ANY ACTION TO ENFORCE THIS AGREEMENT MUST BE BROUGHT IN, AND THE PARTIES HEREBY CONSENT TO THE JURISDICTION OF, A COURT SITUATED IN STATE OF CALIFORNIA.  EACH PARTY HEREBY WAIVES THE RIGHTS TO CLAIM THAT ANY SUCH COURT IS AN INCONVENIENT FORUM FOR THE RESOLUTION OF ANY SUCH ACTION.
11

(f)Resolution of Disputes.  To ensure the rapid and economical resolution of disputes that may arise in connection with Executive’s employment with the Company, Executive and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, Executive’s employment with the Company, or the termination of Executive’s employment, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16, to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS or its successor, under JAMS’ then applicable rules and procedures appropriate to the relief being sought (available upon request and also currently available at the following web addresses: (i) https://www.jamsadr.com/rules-employmentarbitration/ and (ii) https://www.jamsadr.com/rules-comprehensive-arbitration/). Executive acknowledges that by agreeing to this arbitration procedure, both Executive and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.  In addition, all claims, disputes, or causes of action under this section, whether by Executive or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity.  The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding.  To the extent that the preceding sentences regarding class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration.  This paragraph shall not apply to any action or claim that cannot be subject to mandatory arbitration as a matter of law to the extent such claims are not permitted by applicable law(s) to be submitted to mandatory arbitration and the applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the “Excluded Claims”).  In the event Executive intends to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration.  Executive will have the right to be represented by legal counsel at any arbitration proceeding. Questions of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator.  Likewise, procedural questions which grow out of the dispute and bear on the final disposition are also matters for the arbitrator.  The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which the award is based. The arbitrator shall be authorized to award all relief that Executive or the Company would be entitled to seek in a court of law. Executive and the Company shall equally share all JAMS’ arbitration fees, or in such other manner to the extent required by, and in accordance with, applicable law to effectuate Executive’s and the Company’s agreement to arbitrate. Each party is responsible for its own attorneys’ fees, except as expressly set forth in Executive’s Invention, Confidential Information and Non-Competition Agreement. Nothing in this letter agreement is intended to prevent either Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Any awards or orders in such 
12

arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.         
(g)Compliance with Code Section 409A.  It is intended that all of the payments payable under this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code provided under Treasury Regulation Sections 1.409A1(b)(4), 1.409A1(b)(5) and 1.409A1(b)(9), and this Agreement will be construed to the greatest extent possible as consistent with those provisions.  For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A2(b)(2)(iii)), Executive’s right to receive any installment payments under this Agreement (whether Severance Benefits, expense reimbursements or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment under this Agreement shall at all times be considered a separate and distinct payment.  Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company at the time of his Separation from Service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, and if any of the payments, including the Severance Benefits, upon Separation From Service set forth herein and/or under any other agreement with the Company are deemed to be “deferred compensation” (including as a result of the terms of Offer Letter), then to the extent delayed commencement of any portion of such payments is required to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code and the related adverse taxation under Section 409A of the Code, such payments shall not be provided to Executive prior to the earliest of (i) the expiration of the six (6)-month period measured from the date of Executive’s Separation From Service with the Company, (ii) the date of Executive’s death or (iii) such earlier date as permitted under Section 409A of the Code without the imposition of adverse taxation.  Upon the first business day following the expiration of such applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this paragraph shall be paid in a lump sum to Executive, and any remaining payments due shall be paid as otherwise provided in this Agreement or in the applicable agreement.  No interest shall be due on any amounts so deferred.
(h)Severability of Invalid or Unenforceable Provisions.  If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the Parties insofar as possible under applicable law.
(i)Advice of Counsel and Construction.  Each Party acknowledges that such Party had the opportunity to be represented by counsel in the negotiation and execution of this Agreement.  Accordingly, the rule of construction of contract language against the drafting party is hereby waived by each Party.
(j)Entire Agreement.  This Agreement sets forth the entire agreement of the Parties in respect of the subject matter contained herein and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written in respect of the subject matter contained herein. 
13

(k)Withholding Taxes.  The Company shall be entitled to withhold from any payment due to Executive hereunder any amounts required to be withheld by applicable tax laws or regulations. 
(l)Section Headings.  The headings of the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Agreement.
(m)Cooperation.  During the period of Executive’s employment and at any time thereafter, Executive agrees, to the extent permitted by applicable law or the rules of self-regulatory organizations, to cooperate (i) with the Company in the defense of any legal matter involving any matter that arose during Executive’s employment with the Company, and (ii) with all government authorities on matters pertaining to any investigation, litigation or administrative proceeding pertaining to the Company.  For a period of thirty (30) days following termination of Executive’s employment for any reason, Executive shall fully cooperate with the Company in all matters relating to the winding up of Executive’s pending work and the orderly transfer of any such pending work to such other employees as may be designated by the Company. Such cooperation may be performed remotely. The Company will reimburse Executive for any reasonable travel and out of pocket expenses incurred by Executive in providing such cooperation.  The Company shall further reimburse Executive for any reasonable legal fees and costs incurred in complying with this provision.
(n)Survival.  Sections 3(c)(iii), 7, 8(a), 8(b), 8(d), 8(f), 9 and 10 shall survive and continue in full force in accordance with their terms notwithstanding any termination of Executive’s employment with the Company.
(o)Conditions.  This Agreement is subject to satisfactory proof of Executive’s right to work in the United States and, if requested, satisfactory completion of a Company-required background check.  Executive agrees to assist as needed and to complete any documentation at the Company’s request to meet these conditions.
(p)Counterparts.  This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.  This letter may be delivered and executed via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes.

[Signature Page Follow]

14

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written.
APOLLO ENDOSURGERY, INC.

By:  /s/ Charles McKhann                    
    Charles McKhann
    Chief Executive Officer

EXECUTIVE

 Jeff Black                            
Jeff Black

[Signature Page to Employment Agreement]

15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]